Sun Pharma Advanced Research Company Q1 net loss at Rs 2.51 cr

Tags: Companies
Sun Pharma Advanced Research Company today reported a net loss of Rs 2.51 crore for the first quarter ended March 31, 2014, mainly on account of increase in expenses during the period.

The company had posted a net profit of Rs 44.04 crore during the same period of previous fiscal, Sun Pharma Advanced Research Company Ltd (SPARC) said in a statement.

Total income of the company declined to Rs 42.57 crore during the first quarter, as compared to Rs 71.83 crore in the same period of previous fiscal.

The company's expenses during the quarter rose by 78.43 per cent to Rs 48.16 crore in the first quarter, as against Rs 26.99 crore during the same period of previous fiscal.

SPARC was demerged from Sun Pharmaceutical Industries Ltd as a research and drug discovery company in 2007.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • Sebi’s latest ban on 260 entities plugs a major loophole for stock manipulation

    Last week, the capital market regulator, Securities and Exchange Board of India (Sebi) banned 260 entities from dealing in the securities market for m

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Arun Kumar Jain

Nuances in managing joint ventures

This is an age of collaboration. A seemingly simple device ...

Kuruvilla Pandikattu SJ

Finding the missing child of Christmas

Christmas is basically the feast of a helpless child. The ...

Shona Adhikari

Why Indian art auctions are here to stay

With Christie’s second India sale just over in Mumbai, we ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture